SCHEMBL2408455

SCHEMBL2408455

[c]1cccc2c1c[c]c1ccccc12

nearest known ligand 0.31

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2409141 0.85 HPRT1 (0.31)
SCHEMBL17044626 0.83
SCHEMBL17044636 0.82
SCHEMBL2411016 0.82 CYP1A2 (0.32) CYP1A2
SCHEMBL578709 0.79 CYP2A6 (0.32) CYP1A2
SCHEMBL2412656 0.77 HPRT1 (0.33)
SCHEMBL17044600 0.76
SCHEMBL17044592 0.76
SCHEMBL25108 0.74 ALDH1A1 (0.55) CYP1A2
SCHEMBL2408406 0.74 HPRT1 (0.40) CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210069963-A1 METHOD FOR MANUFACTURING A THREE-DIMENSIONAL OBJECT SOLVAY SPECIALITY POLYMERS USA, LLC 2021-03-11 US claimed
CN-111479874-A Method for producing a three-dimensional object 索尔维特殊聚合物美国有限责任公司 2020-07-31 CN claimed
US-9983441-B2 Liquid crystal display device MERCK PATENT GMBH (DE) 2018-05-29 US claimed
US-11654615-B2 Method for manufacturing a three-dimensional object SOLVAY SPECIALTY POLYMERS USA, LLC (US) 2023-05-23 US disclosed
US-20210069963-A1 METHOD FOR MANUFACTURING A THREE-DIMENSIONAL OBJECT SOLVAY SPECIALITY POLYMERS USA, LLC 2021-03-11 US disclosed
CN-111479874-A Method for producing a three-dimensional object 索尔维特殊聚合物美国有限责任公司 2020-07-31 CN disclosed
CN-107109056-B Resin film, which is formed, uses composition and resin film 日产化学工业株式会社 2019-09-03 CN disclosed
US-10059881-B2 Monomer, liquid crystal composition, liquid crystal display device, and production method for liquid crystal display device SHARP KABUSHIKI KAISHA (JP) 2018-08-28 US disclosed
US-9983441-B2 Liquid crystal display device MERCK PATENT GMBH (DE) 2018-05-29 US disclosed
US-20160168465-A1 MONOMER, LIQUID CRYSTAL COMPOSITION, LIQUID CRYSTAL DISPLAY DEVICE, AND PRODUCTION METHOD FOR LIQUID CRYSTAL DISPLAY DEVICE TOYO GOSEI CO., LTD. (JP) 2016-06-16 US disclosed
US-20150261044-A1 LIQUID CRYSTAL DISPLAY DEVICE SHARP KABUSHIKI KAISHA (JP) 2015-09-17 US disclosed
WO-2011105700-A1 NOVEL ORGANIC ELECTROLUMINESCENT COMPOUNDS AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME ROHM AND HAAS ELECTRONIC MATERIALS KOREA LTD. (KR) 2011-09-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10059881-B2 Monomer, liquid crystal composition, liquid crystal display device, and production method for liquid crystal display device SP1, ZYX, NOD1 CYP1A2 1768/4885
US-20160168465-A1 MONOMER, LIQUID CRYSTAL COMPOSITION, LIQUID CRYSTAL DISPLAY DEVICE, AND PRODUCTION METHOD FOR LIQUID CRYSTAL DISPLAY DEVICE SP1, ZYX, NOD1 CYP1A2 1768/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.